Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Editorial: T-Cell Migration in Health and Disease.

Cotta-de-Almeida V, Dupré L, Savino W.

Front Immunol. 2017 Feb 13;8:132. doi: 10.3389/fimmu.2017.00132. eCollection 2017. No abstract available.

2.

Creep turns linear in narrow ferromagnetic nanostrips.

Leliaert J, Van de Wiele B, Vansteenkiste A, Laurson L, Durin G, Dupré L, Van Waeyenberge B.

Sci Rep. 2016 Feb 4;6:20472. doi: 10.1038/srep20472.

3.

T Lymphocyte Migration: An Action Movie Starring the Actin and Associated Actors.

Dupré L, Houmadi R, Tang C, Rey-Barroso J.

Front Immunol. 2015 Nov 18;6:586. doi: 10.3389/fimmu.2015.00586. eCollection 2015. Review.

4.

DC-SIGN-expressing macrophages trigger activation of mannosylated IgM B-cell receptor in follicular lymphoma.

Amin R, Mourcin F, Uhel F, Pangault C, Ruminy P, Dupré L, Guirriec M, Marchand T, Fest T, Lamy T, Tarte K.

Blood. 2015 Oct 15;126(16):1911-20. doi: 10.1182/blood-2015-04-640912. Epub 2015 Aug 13.

5.

A biased competition theory of cytotoxic T lymphocyte interaction with tumor nodules.

Christophe C, Müller S, Rodrigues M, Petit AE, Cattiaux P, Dupré L, Gadat S, Valitutti S.

PLoS One. 2015 Mar 27;10(3):e0120053. doi: 10.1371/journal.pone.0120053. eCollection 2015.

6.

Signal Integration during T Lymphocyte Activation and Function: Lessons from the Wiskott-Aldrich Syndrome.

Cotta-de-Almeida V, Dupré L, Guipouy D, Vasconcelos Z.

Front Immunol. 2015 Feb 9;6:47. doi: 10.3389/fimmu.2015.00047. eCollection 2015. Review.

7.

Highly organised and dense vertical silicon nanowire arrays grown in porous alumina template on <100> silicon wafers.

Gorisse T, Dupré L, Gentile P, Martin M, Zelsmann M, Buttard D.

Nanoscale Res Lett. 2013 Jun 17;8(1):287. doi: 10.1186/1556-276X-8-287.

8.

An initial and rapid step of lytic granule secretion precedes microtubule organizing center polarization at the cytotoxic T lymphocyte/target cell synapse.

Bertrand F, Müller S, Roh KH, Laurent C, Dupré L, Valitutti S.

Proc Natl Acad Sci U S A. 2013 Apr 9;110(15):6073-8. doi: 10.1073/pnas.1218640110. Epub 2013 Mar 27.

9.

Ultradense and planarized antireflective vertical silicon nanowire array using a bottom-up technique.

Dupré L, Gorisse T, Lebranchu AL, Bernardin T, Gentile P, Renevier H, Buttard D.

Nanoscale Res Lett. 2013 Mar 9;8(1):123. doi: 10.1186/1556-276X-8-123.

10.

Wiskott-Aldrich syndrome protein controls antigen-presenting cell-driven CD4+ T-cell motility by regulating adhesion to intercellular adhesion molecule-1.

Lafouresse F, Cotta-de-Almeida V, Malet-Engra G, Galy A, Valitutti S, Dupré L.

Immunology. 2012 Oct;137(2):183-96. doi: 10.1111/j.1365-2567.2012.03620.x.

11.

EVER proteins, key elements of the natural anti-human papillomavirus barrier, are regulated upon T-cell activation.

Lazarczyk M, Dalard C, Hayder M, Dupre L, Pignolet B, Majewski S, Vuillier F, Favre M, Liblau RS.

PLoS One. 2012;7(6):e39995. doi: 10.1371/journal.pone.0039995. Epub 2012 Jun 28.

12.

Stepwise maturation of lytic granules during differentiation and activation of human CD8+ T lymphocytes.

Sanchez-Ruiz Y, Valitutti S, Dupre L.

PLoS One. 2011;6(11):e27057. doi: 10.1371/journal.pone.0027057. Epub 2011 Nov 4.

13.

The Wiskott-Aldrich syndrome protein permits assembly of a focused immunological synapse enabling sustained T-cell receptor signaling.

Calvez R, Lafouresse F, De Meester J, Galy A, Valitutti S, Dupré L.

Haematologica. 2011 Oct;96(10):1415-23. doi: 10.3324/haematol.2011.040204. Epub 2011 Jun 9.

14.

Altered miR-146a expression in Sjögren's syndrome and its functional role in innate immunity.

Pauley KM, Stewart CM, Gauna AE, Dupre LC, Kuklani R, Chan AL, Pauley BA, Reeves WH, Chan EK, Cha S.

Eur J Immunol. 2011 Jul;41(7):2029-39. doi: 10.1002/eji.201040757. Epub 2011 May 27.

15.

Corrigendum to "Evidence for Long-term Efficacy and Safety of Gene Therapy for Wiskott-Aldrich Syndrome in Preclinical Models".

Marangoni F, Bosticardo M, Charrier S, Draghici E, Locci M, Scaramuzza S, Panaroni C, Ponzoni M, Sanvito F, Doglioni C, Liabeuf M, Gjata B, Montus M, Siminovitch K, Aiuti A, Naldini L, Dupré L, Roncarolo MG, Galy A, Villa A.

Mol Ther. 2009 Jul;17(7):1300. doi: 10.1038/mt.2009.61. Epub 2016 Dec 6. No abstract available.

16.

Evidence for long-term efficacy and safety of gene therapy for Wiskott-Aldrich syndrome in preclinical models.

Marangoni F, Bosticardo M, Charrier S, Draghici E, Locci M, Scaramuzza S, Panaroni C, Ponzoni M, Sanvito F, Doglioni C, Liabeuf M, Gjata B, Montus M, Siminovitch K, Aiuti A, Naldini L, Dupré L, Roncarolo MG, Galy A, Villa A.

Mol Ther. 2009 Jun;17(6):1073-82. doi: 10.1038/mt.2009.31. Epub 2009 Mar 3. Erratum in: Mol Ther. 2009 Jul;17(7):1300.

17.

WASP regulates suppressor activity of human and murine CD4(+)CD25(+)FOXP3(+) natural regulatory T cells.

Marangoni F, Trifari S, Scaramuzza S, Panaroni C, Martino S, Notarangelo LD, Baz Z, Metin A, Cattaneo F, Villa A, Aiuti A, Battaglia M, Roncarolo MG, Dupré L.

J Exp Med. 2007 Feb 19;204(2):369-80. Epub 2007 Feb 12.

18.

Impaired humoral immunity in X-linked lymphoproliferative disease is associated with defective IL-10 production by CD4+ T cells.

Ma CS, Hare NJ, Nichols KE, Dupré L, Andolfi G, Roncarolo MG, Adelstein S, Hodgkin PD, Tangye SG.

J Clin Invest. 2005 Apr;115(4):1049-59. Epub 2005 Mar 3.

19.

Single-dose mucosal immunization with biodegradable microparticles containing a Schistosoma mansoni antigen.

Baras B, Benoit MA, Dupré L, Poulain-Godefroy O, Schacht AM, Capron A, Gillard J, Riveau G.

Infect Immun. 1999 May;67(5):2643-8.

Supplemental Content

Loading ...
Support Center